Skip to content

New Owner

Mallinckrodt - Ocera Therapeutics

Mallinckrodt acquires Ocera Therapeutics

Announced: November 02, 2017

Type:           Acquisition
Status:         Pending

Amount:       $ 42,000,000

Acquisition News

Add News

Date Title
There are no news.

Mallinckrodt Other Acquisitions

Add Acquisition

Date Acquired Amount
Aug 04, 2017
InfaCare Pharmaceutical
Undisclosed amount
Aug 10, 2016
Stratatech Corporation
Undisclosed amount
Aug 10, 2015
Therakos
$ 1,330,000,000
Mar 05, 2015
Ikaria
$ 2,300,000,000
Apr 07, 2014
Questcor Pharmaceuticals
Undisclosed amount
View more acquisitions »